Breaking News

MilliporeSigma Invests $25M to Expand Cell Culture Media Production

Boosts capabilities with additional 98,000 sq.-ft. of manufacturing and redesigned lab space.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt Germany, has expanded its facility in Lenexa, KS, adding 98,000 square feet of lab space and production capability to manufacture cell culture media. The company’s strategic investments to expand capacity with the new dry powder media manufacturing lines in existing production facilities in Lenexa and Nantong, China, sites will increase both local and global production to meet current demand and ensure supply f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters